Influence of L-carnitine supplementation on serum lipid profile in hemodialysis patients: a systematic review and meta-analysis
GLP-1 Users for Weight Management represent a 31.8% share, driven by the widespread adoption of GLP-1 receptor agonists specifically for obesity and weight management, along with the corresponding demand for protein, hydration, and micronutrient support to mitigate side effects and maintain nutritional balance
doi:10.1007/s44192-022-00027-w 87
Originally developed for T2D, these agents enhance insulin sensitivity by reducing insulin resistance, as demonstrated by significant declines in Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) scores
10.1001/jama.2023.12876 104 ForstermannU.ClossE
The present review provides (1) an overview in the pathophysiology of NAFLD, including the potential involvement of GLP-1 and glucagon, (2) an introduction to the currently available GLP-1RAs and (3) outlines the potential of emerging GLP-1RAs and GLP-1/glucagon receptor co-agonists in the treatment of NAFLD
